Literature DB >> 17149856

Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1).

Hemaka A Rajapakse1, Philippe G Nantermet, Harold G Selnick, Sanjeev Munshi, Georgia B McGaughey, Stacey R Lindsley, Mary Beth Young, Ming-Tain Lai, Amy S Espeseth, Xiao-Ping Shi, Dennis Colussi, Beth Pietrak, Ming-Chih Crouthamel, Katherine Tugusheva, Qian Huang, Min Xu, Adam J Simon, Lawrence Kuo, Daria J Hazuda, Samuel Graham, Joseph P Vacca.   

Abstract

We describe the discovery and optimization of tertiary carbinamine derived inhibitors of the enzyme beta-secretase (BACE-1). These novel non-transition-state-derived ligands incorporate a single primary amine to interact with the catalytic aspartates of the target enzyme. Optimization of this series provided inhibitors with intrinsic and functional potency comparable to evolved transition state isostere derived inhibitors of BACE-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149856     DOI: 10.1021/jm061046r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

2.  Triazolyl tryptoline derivatives as β-secretase inhibitors.

Authors:  Jutamas Jiaranaikulwanitch; Chantana Boonyarat; Valery V Fokin; Opa Vajragupta
Journal:  Bioorg Med Chem Lett       Date:  2010-09-22       Impact factor: 2.823

3.  Path-integral method for predicting relative binding affinities of protein-ligand complexes.

Authors:  Chandrika Mulakala; Yiannis N Kaznessis
Journal:  J Am Chem Soc       Date:  2009-04-01       Impact factor: 15.419

Review 4.  beta-Secretase as a therapeutic target for Alzheimer's disease.

Authors:  Arun K Ghosh; Sandra Gemma; Jordan Tang
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 5.  The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.

Authors:  Stefania Butini; Simone Brogi; Ettore Novellino; Giuseppe Campiani; Arun K Ghosh; Margherita Brindisi; Sandra Gemma
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 6.  The "Sticky Patch" Model of Crystallization and Modification of Proteins for Enhanced Crystallizability.

Authors:  Zygmunt S Derewenda; Adam Godzik
Journal:  Methods Mol Biol       Date:  2017

Review 7.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

8.  From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease.

Authors:  Jutamas Jiaranaikulwanitch; Piyarat Govitrapong; Valery V Fokin; Opa Vajragupta
Journal:  Molecules       Date:  2012-07-10       Impact factor: 4.411

9.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

10.  Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE).

Authors:  Shu Liu; Rao Fu; Xiao Cheng; Sheng-Ping Chen; Li-Hua Zhou
Journal:  BMC Struct Biol       Date:  2012-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.